[Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma].
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D015251:Epirubicin; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D013237:Stereoisomerism
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D004317:Doxorubicin
Attività terapeutica della epirubicina nel melanoma maligno e nei linfomi non-Hodgkin.